{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T20:18:04Z","timestamp":1696796284531},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1007\/bf02967166","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T00:51:58Z","timestamp":1223340718000},"page":"187-191","source":"Crossref","is-referenced-by-count":1,"title":["MFL-P chemotherapy for pretreated metastatic Breast Cancer patients: A regimen with triple biochemical modulation by MTX-5FU, LV-5FU and 5FU-CDDP"],"prefix":"10.1007","volume":"6","author":[{"given":"Norimichi","family":"Kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"(suppl 2)","key":"BF02967166_CR1","first-page":"32","volume":"10","author":"HW Bruckner","year":"1983","unstructured":"Bruckner HW, Cohen J: MTX\/5-FU trials in gastrointestinal and other cancer.Semin Oncol 10 (suppl 2):32\u201339, 1983.","journal-title":"Semin Oncol"},{"key":"BF02967166_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/07357908909038266","volume":"7","author":"JJ Gohdmann","year":"1989","unstructured":"Gohdmann JJ, Macdonald JS: Chemotherapy of gastric cancer.Cancer Invest 7:39\u201352, 1989.","journal-title":"Cancer Invest"},{"key":"BF02967166_CR3","first-page":"833","volume":"28","author":"N Kan","year":"1994","unstructured":"Kan N, Okino T, Inoue K,et al: Evaluation of outpatient cisplatin for patients with advanced or recurrent gastric cancer; Combination with immunotherapy or other anti-cancer agents.Kiso to Rinsyou 28:833\u2013841, 1994(in Japanese with English abstract).","journal-title":"Kiso to Rinsyou"},{"key":"BF02967166_CR4","first-page":"l","volume-title":"General Rules for Reporting on Clinical Oncology","author":"Japanese Society for Cancer Therapy","year":"1991","unstructured":"Japanese Society for Cancer Therapy: General Rules for Reporting on Clinical Oncology, 1st ed, Kanehara, Tokyo, ppl-101, 1991.","edition":"1st ed"},{"key":"BF02967166_CR5","first-page":"l","volume-title":"General Rules for Clinical and Pathological Recording of Breast Cancer","author":"Japanese Breast Cancer Society","year":"1996","unstructured":"Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 12th ed, Kanehara, Tokyo, ppl-68, 1996.","edition":"12th ed"},{"key":"BF02967166_CR6","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1073\/pnas.83.23.8923","volume":"83","author":"KJ Scanlon","year":"1986","unstructured":"Scanlon KJ, Newman EM, Lu Y,et al: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proc Natl Acad Sci USA 83:8923\u20138925, 1986.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02967166_CR7","first-page":"654","volume":"27","author":"A Nashimoto","year":"1992","unstructured":"Nashimoto A, Sasaki J, Akai S,et al: Ambulatory combination chemotherapy with cisplatin and 5-fluorouracil for advanced gastric cancer patients.J Jpn Soc Cancer Ther 27:654\u2013664, 1992.","journal-title":"J Jpn Soc Cancer Ther"},{"key":"BF02967166_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.1988.6.7.1197","volume":"6","author":"ET Creagan","year":"1988","unstructured":"Creagan ET, Richardson RL, Kavach JS: Pilot study of a continuous five-day intravenous infusion of etopo-side concomitant with cisplatin in selected patients with advanced cancer.J Clin Oncol 6:1197\u20131201, 1988.","journal-title":"J Clin Oncol"},{"key":"BF02967166_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/1097-0142(19910101)67:1<14::AID-CNCR2820670104>3.0.CO;2-M","volume":"67","author":"JJ Lokich","year":"1991","unstructured":"Lokich JJ, Ahlgren JD, Cantrell J,et al: A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma; A Mid-Atlantic Oncology Program study.Cancer 67:14\u201319, 1991.","journal-title":"Cancer"},{"key":"BF02967166_CR10","first-page":"929","volume":"37","author":"S Suga","year":"1991","unstructured":"Suga S, Kimura K, Nagai H,et al: An evaluation of gastric cancers given UFT\/CDDP chemotherapy.Gan no Rinsyou 37:929\u2013939, 1991(in Japanese with English abstract).","journal-title":"Gan no Rinsyou"},{"key":"BF02967166_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001813-199803000-00002","volume":"9","author":"U Klaassen","year":"1998","unstructured":"Klaassen U, Wilke H, Weyhofen R,et al: Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil\/leucovorin for first-line treatment of metastatic breast cancer.Anti-Cancer Drugs 9:203\u2013207, 1998.","journal-title":"Anti-Cancer Drugs"},{"key":"BF02967166_CR12","first-page":"1907","volume":"23","author":"T Sasaki","year":"1996","unstructured":"Sasaki T: Sequential methotrexate and 5-fluorouracil.Jpn J Cancer Chemother 23:1907\u20131910, 1996.","journal-title":"Jpn J Cancer Chemother"},{"key":"BF02967166_CR13","first-page":"957","volume":"31","author":"S Oura","year":"1996","unstructured":"Oura S, Sakura T, Yoshimura G,et al: Result of biochemical modulation therapy of 5-FU with low dose cisplatin for anthracycline resistant breast carcinoma.J Jpn Soc Cancer Ther 31:957\u2013964, 1996.","journal-title":"J Jpn Soc Cancer Ther"},{"key":"BF02967166_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/030089169608200113","volume":"82","author":"V Alonso","year":"1996","unstructured":"Alonso V, Santander C, Florian J,et al: Phase II trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer.Tumori 82:61\u201364, 1996.","journal-title":"Tumori"},{"key":"BF02967166_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s002800050447","volume":"38","author":"MC Haaz","year":"1996","unstructured":"Haaz MC, Fischel JL, Forment P,et al: Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase.Cancer Chemother Pharmacol 38:52\u201358, 1996.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02967166_CR16","first-page":"l819","volume-title":"Progress in Gastric Cancer Research 1997","author":"T Okino","year":"1997","unstructured":"Okino T, Kan N, Satoh K,et al: Therapeutic effect of sequential chemotherapy using methotrexate, 5-FU, leucovorin and cisplatin (MFLP) against advanced and\/or recurrent gastric cancer. In: Siewert JR, Roder JD eds, Progress in Gastric Cancer Research 1997, Monduzzi Editore SpA, Bologna, ppl819\u20131823, 1997."},{"key":"BF02967166_CR17","first-page":"237","volume":"21","author":"G Platesi","year":"1988","unstructured":"Platesi G, Gianni L, Manzotti C,et al: Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice.Cancer Chemother Pharmacol 21:237\u2013240, 1988.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02967166_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00685944","volume":"29","author":"M Kuroki","year":"1992","unstructured":"Kuroki M, Nakano S, Mitsugi K,et al:In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line.Cancer Chemother Pharmacol 29:273\u2013276, 1992.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02967166_CR19","first-page":"419","volume":"16","author":"S Furukawa","year":"1989","unstructured":"Furukawa S, Yoshida T, Tukuda M,et al: Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil.Jpn J Cancer Chemother 16(part-I):419\u2013422, 1989.","journal-title":"Jpn J Cancer Chemother"},{"key":"BF02967166_CR20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<479::AID-IJC15>3.0.CO;2-5","volume":"65","author":"T Esaki","year":"1996","unstructured":"Esaki T, Nakano S, Matsumoto N,et al: Schedule-dependent reversion by 5-fluorouracil in a newly established cisplatin-resistent HST-1 human squamous carcinoma cell line.Int J Cancer 65:479\u2013484, 1996.","journal-title":"Int J Cancer"},{"key":"BF02967166_CR21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2169\/internalmedicine.34.288","volume":"34","author":"S Nakano","year":"1995","unstructured":"Nakano S, Niho Y: 5-Fluorouracil and cisplatin sequential chemotherapy; Mechanism of action and clinical application in advanced, unresectable non-small cell lung cancer.Intern Med 34:288\u2013291, 1995.","journal-title":"Intern Med"},{"key":"BF02967166_CR22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00004836-199108000-00005","volume":"13","author":"HW Bruckner","year":"1991","unstructured":"Bruckner HW, Chesser MR, Wong H,et al: Folate biochemical modulation regimen for the treatment of gastric cancer.J Clin Gastroenterol 13:384\u2013389, 1991.","journal-title":"J Clin Gastroenterol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02967166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02967166\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02967166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T17:11:15Z","timestamp":1558458675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02967166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["BF02967166"],"URL":"https:\/\/doi.org\/10.1007\/bf02967166","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}